Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Add filters

Year range
Braz. j. med. biol. res ; 47(4): 299-306, 8/4/2014. graf
Article in English | LILACS | ID: lil-705762


Notch signaling plays a vital role in tumorigenicity and tumor progression by regulating proliferation, invasion, and the tumor microenvironment. Previous research by our group indicated that Notch ligand Delta-like 1 (Dll1) is involved in angiogenesis in melanoma, and we noticed that it took a longer time to trypsinize Dll1-expressing B16 melanoma cells than the control cells. In this article, we extended our study to investigate the effects of Dll1 on tumor cell adhesion and metastasis. Dll1 overexpression activated Notch signaling in B16 tumor cells and significantly enhanced the adhering capacity of B16 tumor cells both in vitro and in vivo. B16-Dll1 cells also had a higher metastatic potential than their counterpart in the mouse model of lung metastasis. Along with increased Dll1 expression, N-cadherin, but not E-cadherin, was upregulated in B16-Dll1 cells. These data suggested that Notch ligand Dll1 may enhance the adhesion and metastasis of melanoma cells by upregulation of N-cadherin.

Animals , Cadherins/biosynthesis , Intercellular Signaling Peptides and Proteins/metabolism , Lung Neoplasms/secondary , Melanoma, Experimental/secondary , Membrane Proteins/metabolism , Signal Transduction/genetics , Blotting, Western , Cell Adhesion , Cell Culture Techniques , Cell Line, Tumor , Gene Expression , Green Fluorescent Proteins , Human Umbilical Vein Endothelial Cells/physiology , Melanoma, Experimental/pathology , Real-Time Polymerase Chain Reaction , Up-Regulation
Clinics ; 68(7): 1018-1027, jul. 2013. graf
Article in English | LILACS | ID: lil-680698


OBJECTIVE: Available chemotherapy presents poor control over the development of metastatic melanoma. FTY720 is a compound already approved by the Food and Drug Administration for the treatment of patients with multiple sclerosis. It has also been observed that FTY720 inhibits tumor growth in vivo (experimental models) and in vitro (animal and human tumor cells). The aim of this study was to evaluate the effects of FTY720 on a metastatic melanoma model and in tumor cell lines. METHODS: We analyzed FTY720 efficacy in vivo in a syngeneic murine metastatic melanoma model, in which we injected tumor cells intravenously into C57BL/6 mice and then treated the mice orally with the compound for 7 days. We also treated mice and human tumor cell lines with FTY720 in vitro, and cell viability and death pathways were analyzed. RESULTS: FTY720 treatment limited metastatic melanoma growth in vivo and promoted a dose-dependent decrease in the viability of murine and human tumor cells in vitro. Melanoma cells treated with FTY720 exhibited characteristics of programmed cell death, reactive oxygen species generation, and increased β-catenin expression. In addition, FTY720 treatment resulted in an immunomodulatory effect in vivo by decreasing the percentage of Foxp3+ cells, without interfering with CD8+ T cells or lymphocyte-producing interferon-gamma. CONCLUSION: Further studies are needed using FTY720 as a monotherapy or in combined therapy, as different types of cancer cells would require a variety of signaling pathways to be extinguished. .

Animals , Humans , Male , Mice , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Immunosuppressive Agents/therapeutic use , Lung Neoplasms/drug therapy , Melanoma, Experimental/drug therapy , Propylene Glycols/therapeutic use , Sphingosine/analogs & derivatives , Blotting, Western , Cell Line, Tumor , Cell Survival , /drug effects , Drug Screening Assays, Antitumor/methods , Flow Cytometry , Lung Neoplasms/secondary , Microscopy, Electron, Transmission , Melanoma, Experimental/pathology , Melanoma, Experimental/secondary , Reactive Oxygen Species , Sphingosine/therapeutic use , Time Factors
Braz. j. med. biol. res ; 41(4): 305-310, Apr. 2008. ilus, tab
Article in English | LILACS | ID: lil-479684


We showed that guaraná (Paullinia cupana Mart var. sorbilis) had a chemopreventive effect on mouse hepatocarcinogenesis and reduced diethylnitrosamine-induced DNA damage. In the present experiment, we evaluated the effects of guaraná in an experimental metastasis model. Cultured B16/F10 melanoma cells (5 x 10(5) cells/animal) were injected into the tail vein of mice on the 7th day of guaraná treatment (2.0 mg P. cupana/g body weight, per gavage) and the animals were treated with guaraná daily up to 14 days until euthanasia (total treatment time: 21 days). Lung sections were obtained for morphometric analysis, apoptotic bodies were counted to calculate the apoptotic index and proliferating cell nuclear antigen-positive cells were counted to determine the proliferation index. Guaraná-treated (GUA) animals presented a 68.6 percent reduction in tumor burden area compared to control (CO) animals which were not treated with guaraná (CO: 0.84 ± 0.26, N = 6; GUA: 0.27 ± 0.24, N = 6; P = 0.0043), a 57.9 percent reduction in tumor proliferation index (CO: 23.75 ± 20.54, N = 6; GUA: 9.99 ± 3.93, N = 6; P = 0.026) and a 4.85-fold increase in apoptotic index (CO: 66.95 ± 22.95, N = 6; GUA: 324.37 ± 266.74 AB/mm², N = 6; P = 0.0152). In this mouse model, guaraná treatment decreased proliferation and increased apoptosis of tumor cells, consequently reducing the tumor burden area. We are currently investigating the molecular pathways of the effects of guaraná in cultured melanoma cells, regarding principally the cell cycle inhibitors and cyclins.

Animals , Female , Mice , Antineoplastic Agents, Phytogenic/therapeutic use , Cell Proliferation/drug effects , Lung Neoplasms/prevention & control , Melanoma, Experimental/prevention & control , Paullinia/chemistry , Plant Extracts/therapeutic use , Lung Neoplasms/secondary , Mice, Inbred BALB C , Melanoma, Experimental/secondary , Proliferating Cell Nuclear Antigen/analysis
Indian J Exp Biol ; 2004 Oct; 42(10): 976-80
Article in English | IMSEAR | ID: sea-59433


Mouse B16LuF1 melanoma cells of lower metastatic potential to lung were treated in vitro with same concentration (50 microM) of gangliosides prepared from plasma of mice bearing lung metastasis of B16LuF5, B16LuF9 or B16LuF10 melanoma cell lines of increasing metastatic potential to lung (LuF1 < LuF5 < LuF9 < LuF10) and injected to normal mice through tail vein. The number of metastatic tumor nodules formed in lung increased gradually in mice receiving B16LuF5, B16LuF9 and B16LuF10-ganglioside-treated B16LuF1 cells compared to mice receiving B16LuF1 cells without any ganglioside treatment. Similarly, mouse B16LuF1 melanoma cells treated in vitro with 50 microM concentration of gangliosides prepared from spent culture media of B16LuF5, B16LuF9 or B16LuF10 cells cultured in vitro were injected to normal mice through tail vein. The number of metastatic tumor nodules formed in lung increased gradually in mice receiving B16LuF5, B16LuF9 and B16LuF10-ganglioside-treated B16LuF1 cells compared to mice receiving B16LuF1 cells without any ganglioside treatment. The results indicated that metastasis-associated gangliosides present in plasma and culture media of B16-melanoma of increasing metastatic potential to lung enhanced metastatic potential of B16LuF1 cells. The increasing concentration of metastasis-associated gangliosides present in plasma and in culture media of B16-melanoma of increasing metastatic potential possibly determined increase in metastatic potential of B16LuF1-melanoma cells.

Animals , Cell Line, Tumor , Culture Media, Conditioned , Gangliosides/blood , Lung Neoplasms/secondary , Melanoma, Experimental/secondary , Mice , Mice, Inbred C57BL